MustGrow Biologics (TSXV:MGRO) Debt-to-Equity : 0.14 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics Debt-to-Equity?

MustGrow Biologics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.62 Mil. MustGrow Biologics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.14 Mil. MustGrow Biologics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$5.58 Mil. MustGrow Biologics's debt to equity for the quarter that ended in Dec. 2023 was 0.14.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MustGrow Biologics's Debt-to-Equity or its related term are showing as below:

TSXV:MGRO' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.46 Med: 0.14 Max: 0.39
Current: 0.14

During the past 8 years, the highest Debt-to-Equity Ratio of MustGrow Biologics was 0.39. The lowest was -1.46. And the median was 0.14.

TSXV:MGRO's Debt-to-Equity is ranked better than
72.69% of 216 companies
in the Agriculture industry
Industry Median: 0.35 vs TSXV:MGRO: 0.14

MustGrow Biologics Debt-to-Equity Historical Data

The historical data trend for MustGrow Biologics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics Debt-to-Equity Chart

MustGrow Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.32

0.39

0.09

0.15

0.14

MustGrow Biologics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.13	0.15	0.18	0.31	0.14

Competitive Comparison of MustGrow Biologics's Debt-to-Equity

For the Agricultural Inputs subindustry, MustGrow Biologics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MustGrow Biologics's Debt-to-Equity Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MustGrow Biologics's Debt-to-Equity falls into.

MustGrow Biologics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MustGrow Biologics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.618	+	0.141)	/	5.584
	=	0.14

MustGrow Biologics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.618	+	0.141)	/	5.584
	=	0.14

MustGrow Biologics (TSXV:MGRO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

MustGrow Biologics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MustGrow Biologics (TSXV:MGRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

MGROF:USA 0C0:Germany

Address

1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5

Website

https://www.mustgrow.ca

MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for the control of nematodes, soil-borne diseases, and other soil pests.

MustGrow Biologics (TSXV:MGRO) Headlines

No Headlines